本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

1.06
+0.5724117.39%
盘后0.9296-0.1304-12.30%19:59 EST
成交量:1.60亿
成交额:1.65亿
市值:789.02万
市盈率:-0.33
高:1.34
开:0.5100
低:0.5069
收:0.4876
52周最高:3.85
52周最低:0.2810
股本:744.36万
流通股本:733.12万
量比:9.36
换手率:2175.95%
股息:- -
股息率:- -
每股收益(TTM):-3.2501
每股收益(LYR):-12.6857
净资产收益率:-89.90%
总资产收益率:-53.70%
市净率:0.65
市盈率(LYR):-0.08

数据加载中...

2022/11/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report
2022/06/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report
2022/06/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership